KSS climbed nearly 12% on the week to $18.27, yet short sellers barely flinched — a divergence that frames the central question around the stock right now.
The short position is genuinely heavy. At 27.8% of the free float, roughly one in four shares is sold short, and that figure has barely moved despite the rally: short interest ticked up just 0.26% week-on-week. The absence of any meaningful covering after a double-digit price move says the bears are not yet persuaded. The ORTEX short score reinforces that — currently at 69.9, it has held in a tight band between 68 and 71 over the past two weeks, showing no sign of the kind of conviction unwind that precedes a real squeeze. Borrow conditions, however, offer shorts little friction: cost to borrow is just 0.50%, and availability runs at 223%, meaning roughly two shares are available for every one already borrowed. That is a comfortable lending market with no mechanical pressure forcing positions closed. Options pricing is a shade more relaxed than usual, with the put/call ratio at 1.06 — below its 20-day average of 1.10 and well off the 52-week high of 1.49. The week's rally appears to have drawn some hedges off the table.
The Street remains broadly skeptical. Both JP Morgan and Morgan Stanley carry Underweight ratings, with targets of $17 and $15 respectively — below where the stock currently trades. Baird lifted its target to $20 after last month's print but stayed at Neutral. Citigroup is the lone Buy with a $22 target. The mean target across the group sits at $18.73, implying a stock that is essentially fairly valued at current levels on the Street's own numbers. The bull case centres on Kohl's proprietary brand mix, the Sephora partnership, and gradual inventory discipline; the bear case points to a predominantly low- and middle-income customer base, structurally challenged foot traffic, and online competition continuing to erode the department store model. EPS momentum is a rare bright spot — ranking in the 97th percentile on a 30-day basis and 87th percentile over 90 days — suggesting estimate revisions have been running hot into the November earnings date. The PE, near 10.8x and down roughly 1.7 turns over the past month as the stock has outpaced earnings expectations, keeps the value case alive alongside a price-to-book of 0.47x.
Institutional flows add a layer of interest. BlackRock is by far the largest holder at 18.5% of shares, and its most recent 13G/A filing last July showed a step-up from 12% to 14.8%. American Century and Dimensional both added modestly through August. There are no 13D activists on the register — no activist is pressing for change — and all five Schedule 13D/G filers are passive in their filings. The 13D/G register carries the standard caveat: stakes are as-last-disclosed around the 5% threshold, and holders dropping below may not file again. On the insider side, the 90-day net is modestly negative at –$760k, but the two meaningful open-market sales in early August — from the CLO and Chief Marketing Officer — were both executed under pre-arranged 10b5-1 plans, which reduces their signal value considerably. Recent activity on the grant side is compensation mechanics rather than conviction.
The closest peer, M, rose only 3.2% on the week against KSS's 12% gain. DDS added just over 1%. That gap is large enough to raise the question of whether KSS's move was driven by fundamental reassessment or by short-covering pressure that didn't show up in the headline SI data — perhaps concentrated in specific expirations rather than the underlying borrow.
The next scheduled catalyst is the November 25 earnings print. With the short score stable near 70, the lending market loose, and analyst targets clustered just around the current price, the tape into that date is less about whether a squeeze materialises and more about whether the EPS momentum that has been driving estimate revisions can survive the consumer spending backdrop that Kohl's core customer faces.
See the live data behind this article on ORTEX.
Open KSS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
